Sign in

NCT05761249Completed

BIOSTREAM.HF HeartInsight

Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices - HeartInsight Substudy

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

The main goal is to learn how HeartInsight is used in clinical routine care. HeartInsight is a heart failure monitoring and notification tool within BIOTRONIK's Home Monitoring System. HeartInsight combines patient data as collected by the implanted devices to alert the attending physicians to impending worsening of heart failure events of the patients. This study will create a sound and seamless documentation of approximately 150 HeartInsight alerts, their processing, subsequent interventions and disease progressions. The data will be analyzed to characterize and quantify the use of HeartInsight in a clinical routine set-up.The patient population consists of heart failure patients with BIOTRONIK CRT-D devices that support HeartInsight.

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
7 Feb 2023
Start date
2 May 2023
Primary completion date
9 Jul 2025
Lead sponsor
Biotronik SE & Co. KG
NCT number
NCT05761249

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 2 May 2023 to the primary completion date, 9 Jul 2025
  • 7 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of patient incompliance

Other

  • Patient with permanent atrial fibrillation or 100% atrial pacing
  • Patient is not implanted with an atrial or DX lead or atrial sensing is deactivated

Who the study is looking for

  • Patient willing and able to give consent
  • Participation in BIO\|STREAM.HF
  • HeartInsight-capable CRT-D device implanted or planned to be implanted
  • Symptomatic heart failure NYHA class II or III within 45 days prior to enrollment
  • HeartInsight score available or planned use of HeartInsight
  • History of worsening of heart failure hospitalization or unscheduled outpatient visit with intravenous diuretic therapy for acute worsening of heart failure
  • Patient is willing and able to utilize BIOTRONIK Home Monitoring via CardioMessenger and has sufficient mobile network coverage

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Nemocnice České Budějovice, a.s.
Coordinator of this site? Confirm its status
České BudějoviceCzechiaUnknown status
Fakultni nemocnice Olomouc
Coordinator of this site? Confirm its status
OlomoucCzechiaUnknown status
CHU de Brest
Coordinator of this site? Confirm its status
BrestFranceUnknown status
Semmelweis University
Coordinator of this site? Confirm its status
BudapestHungaryUnknown status
The University of Pécs
Coordinator of this site? Confirm its status
PécsHungaryUnknown status
Pauls Stradins Clinical University Hospital
Coordinator of this site? Confirm its status
RigaLatviaUnknown status
Hospital De Santa Maria
Coordinator of this site? Confirm its status
LisbonPortugalUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.